Prenetics Announces First Quarter 2025 Financial Results, Raises FY2025 Outlook, & Crypto Strategy Announcement Soon
Revenue grew 336.5% to $14.4 million from prior year (excluding ACT Genomics)Raises full year revenue outlook to $80 - $100...
DNA
Prenetics Announces First Quarter 2025 Financial Results, Raises FY2025 Outlook, & Crypto Strategy Announcement Soon
Revenue grew 336.5% to $14.4 million from prior year (excluding ACT Genomics)Raises full year revenue outlook to $80 - $100...
Prenetics Announces First Quarter 2025 Financial Results, Raises FY2025 Outlook, & Crypto Strategy Announcement Soon
Revenue grew 336.5% to $14.4 million from prior year (excluding ACT Genomics)Raises full year revenue outlook to $80 - $100...
Simpli5 Celebrates 15 Years of Revolutionizing Team Performance Through Energy Dynamics
AUSTIN, Texas, June 11, 2025 /PRNewswire/ -- Simpli5, the innovative platform powered by the 5 Dynamics methodology, proudly celebrates 15...
vTv Therapeutics to Participate in the H.C. Wainwright “HCW@Home” Series
HIGH POINT, N.C., June 11, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on...
Cogent Biosciences Secures up to $400 Million in Non-Dilutive Financing
Facility provides additional funding for next steps of the Company’s growth, including the expected launch of bezuclastinib in 2026 On...
Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress
– 7 of 8 myositis patients achieved clinically meaningful TIS responses after discontinuation of all immunomodulators, while off or actively...
Basecamp Research Announces Breakthrough Discovery of Over One Million New Species, Yielding Enormous New Database Purpose-Built for Generative Foundation Models in Biology
Head to Head Comparison Size and Diversity: Protein Model Training Datasets 10X Tree of Life Expanding Our View of The...
lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics
SAN DIEGO, June 10, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), aligned with its commitments to advance the power of...
Nexus IT Secures $60M Investment to Accelerate Founder-Led, Values-Driven MSP/MSSP Expansion
New investment from Metropolitan Partners Group positions Nexus IT to lead a values-aligned M&A model reshaping the managed services landscape. SALT LAKE CITY, June 10, 2025 /PRNewswire/ -- Nexus IT, a nationally recognized Managed Services...
Ascend Completes GMP Certification for Quality Control Testing in Munich Facility
- Enables streamlined stability testing and release of higher quality AAV-based gene therapy products. - Provides much needed European capacity...
Roji Health Intelligence Achieves HITRUST e1 Certification Demonstrating Foundational Cybersecurity
HITRUST e1 Certification validates Roji Health Intelligence is committed to foundational cybersecurity controls and information risk managementCHICAGO, June 10, 2025...
Vivex® Biologics, Inc. Appoints Industry Veteran Jon E. Block, Ph.D., as Chief Clinical Officer
Dr. Jon Block to Lead Vivex’s Completion of its Ascend and Restore Randomized Clinical Trials for VIA Disc® NP, Vivex’s...
Chen Institute Opens Public Registration for Symposium on AI Accelerated Science
Join Us in San Francisco, October 27-28! REDWOOD CITY, Calif., June 9, 2025 /PRNewswire/ -- The Tianqiao and Chrissy Chen...
NSCEB Announces Biotech Across America Roadshow, Makes First Stop in North Carolina
NSCEB is launching a 3-month tour of the booming U.S. biotechnology ecosystem RALEIGH, N.C., June 6, 2025 /PRNewswire/ -- Yesterday,...
Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the 2025 European Hematology Association (EHA) Annual Meeting
– Company to showcase preclinical studies of ARV-393, an investigational oral PROTAC BCL6 degrader, as a single agent in models...
Nucleus Genomics Launches Nucleus Embryo, Genetic Optimization Software Alongside Partnership with Genomic Prediction
Parents pursuing IVF now have a new level of choice to empower their family planning NEW YORK, June 4, 2025...
aTyr Pharma Announces Findings from Interim Analysis of Ongoing Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD)
Three out of four efzofitimod-treated diffuse SSc-ILD patients showed clinically important improvement based on the modified Rodnan Skin Score (mRSS)...
Apellis Pharmaceuticals to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
WALTHAM, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at...
Sionna Therapeutics Announces Positive Phase 1 Data for NBD1 Stabilizers SION-719 and SION-451 and Advances Both Programs in Clinical Development for Cystic Fibrosis
SION-719 and SION-451 were generally well tolerated and achieved desired pharmacokinetic targets that reinforce their potential as either an add-on...